137 related articles for article (PubMed ID: 22911825)
1. The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals.
Jung K; Wang Q; Kim Y; Scheuer K; Zhang Z; Shen Q; Chang KO; Saif LJ
PLoS One; 2012; 7(7):e41619. PubMed ID: 22911825
[TBL] [Abstract][Full Text] [Related]
2. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency.
Lei S; Ryu J; Wen K; Twitchell E; Bui T; Ramesh A; Weiss M; Li G; Samuel H; Clark-Deener S; Jiang X; Lee K; Yuan L
Sci Rep; 2016 Apr; 6():25222. PubMed ID: 27118081
[TBL] [Abstract][Full Text] [Related]
3. Human norovirus cultivation systems and their use in antiviral research.
Hayashi T; Kobayashi S; Hirano J; Murakami K
J Virol; 2024 Apr; 98(4):e0166323. PubMed ID: 38470106
[TBL] [Abstract][Full Text] [Related]
4. Norovirus Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced JAK/STAT Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses.
Hosmillo M; Chaudhry Y; Nayak K; Sorgeloos F; Koo BK; Merenda A; Lillestol R; Drumright L; Zilbauer M; Goodfellow I
mBio; 2020 Mar; 11(2):. PubMed ID: 32184238
[TBL] [Abstract][Full Text] [Related]
5. Replication of Human Norovirus in Human Intestinal Enteroids Is Affected by Fecal Sample Processing.
Narwankar R; Esseili MA
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400017
[TBL] [Abstract][Full Text] [Related]
6. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity.
Lewis MA; Cortés-Penfield NW; Ettayebi K; Patil K; Kaur G; Neill FH; Atmar RL; Ramani S; Estes MK
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0063623. PubMed ID: 37787556
[TBL] [Abstract][Full Text] [Related]
7. Vero Cells as a Mammalian Cell Substrate for Human Norovirus.
Todd KV; Tripp RA
Viruses; 2020 Apr; 12(4):. PubMed ID: 32295124
[TBL] [Abstract][Full Text] [Related]
8. Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients.
Kreins AY; Roux E; Pang J; Cheng I; Charles O; Roy S; Mohammed R; Owens S; Lowe DM; Brugha R; Williams R; Howley E; Best T; Davies EG; Worth A; Solas C; Standing JF; Goldstein RA; Rocha-Pereira J; Breuer J
Clin Immunol; 2024 Feb; 259():109901. PubMed ID: 38218209
[TBL] [Abstract][Full Text] [Related]
9. Optimizing Human Intestinal Enteroids for Environmental Monitoring of Human Norovirus.
Overbey KN; Zachos NC; Coulter C; Schwab KJ
Food Environ Virol; 2021 Dec; 13(4):470-484. PubMed ID: 34191266
[TBL] [Abstract][Full Text] [Related]
10. Norovirus Cell Tropism Is Determined by Combinatorial Action of a Viral Non-structural Protein and Host Cytokine.
Lee S; Wilen CB; Orvedahl A; McCune BT; Kim KW; Orchard RC; Peterson ST; Nice TJ; Baldridge MT; Virgin HW
Cell Host Microbe; 2017 Oct; 22(4):449-459.e4. PubMed ID: 28966054
[TBL] [Abstract][Full Text] [Related]
11. Murine Norovirus Infection Induces T
Bouziat R; Biering SB; Kouame E; Sangani KA; Kang S; Ernest JD; Varma M; Brown JJ; Urbanek K; Dermody TS; Ng A; Hinterleitner R; Hwang S; Jabri B
Cell Host Microbe; 2018 Nov; 24(5):677-688.e5. PubMed ID: 30392830
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus.
Ingle H; Makimaa H; Aggarwal S; Deng H; Foster L; Li Y; Kennedy EA; Peterson ST; Wilen CB; Lee S; Suthar MS; Baldridge MT
Sci Adv; 2023 Sep; 9(37):eadi2562. PubMed ID: 37703370
[TBL] [Abstract][Full Text] [Related]
13. Virucidal Effects of Dielectric Barrier Discharge Plasma on Human Norovirus Infectivity in Fresh Oysters (
Choi MS; Jeon EB; Kim JY; Choi EH; Lim JS; Choi J; Ha KS; Kwon JY; Jeong SH; Park SY
Foods; 2020 Nov; 9(12):. PubMed ID: 33255577
[TBL] [Abstract][Full Text] [Related]
14. Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age.
Bui T; Kocher J; Li Y; Wen K; Li G; Liu F; Yang X; LeRoith T; Tan M; Xia M; Zhong W; Jiang X; Yuan L
J Gen Virol; 2013 Sep; 94(Pt 9):2005-2016. PubMed ID: 23804568
[TBL] [Abstract][Full Text] [Related]
15. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.
Baldridge MT; Nice TJ; McCune BT; Yokoyama CC; Kambal A; Wheadon M; Diamond MS; Ivanova Y; Artyomov M; Virgin HW
Science; 2015 Jan; 347(6219):266-9. PubMed ID: 25431490
[TBL] [Abstract][Full Text] [Related]
16. The molecular pathology of noroviruses.
Karst SM; Zhu S; Goodfellow IG
J Pathol; 2015 Jan; 235(2):206-16. PubMed ID: 25312350
[TBL] [Abstract][Full Text] [Related]
17. Chemokine CCL6 Plays Key Role in the Inhibitory Effect of Vitamin A on Norovirus Infection.
Lee H; Lee G; Cho YH; Song Y; Ko G
J Microbiol; 2023 May; 61(5):579-587. PubMed ID: 37233907
[TBL] [Abstract][Full Text] [Related]
18. Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency.
van Kampen JJA; Dalm VASH; Fraaij PLA; Oude Munnink BB; Schapendonk CME; Izquierdo-Lara RW; Villabruna N; Ettayebi K; Estes MK; Koopmans MPG; de Graaf M
J Infect Dis; 2022 Nov; 226(10):1781-1789. PubMed ID: 35255136
[TBL] [Abstract][Full Text] [Related]
19. Endosomal Cholesterol in Viral Infections - A Common Denominator?
Glitscher M; Hildt E
Front Physiol; 2021; 12():750544. PubMed ID: 34858206
[TBL] [Abstract][Full Text] [Related]
20. Interferon responses to norovirus infections: current and future perspectives.
Jahun AS; Goodfellow IG
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34698626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
